<SEC-DOCUMENT>0001493152-20-013713.txt : 20200721
<SEC-HEADER>0001493152-20-013713.hdr.sgml : 20200721
<ACCEPTANCE-DATETIME>20200721170647
ACCESSION NUMBER:		0001493152-20-013713
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200718
FILED AS OF DATE:		20200721
DATE AS OF CHANGE:		20200721

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Buell Jennifer
		CENTRAL INDEX KEY:			0001711184

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-51353
		FILM NUMBER:		201039471

	BUSINESS ADDRESS:	
		BUSINESS PHONE:		781-674-4400

	MAIL ADDRESS:	
		STREET 1:		3 FORBES ROAD
		CITY:			LEXINGTON
		STATE:			MA
		ZIP:			02421

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Protagenic Therapeutics, Inc.\new
		CENTRAL INDEX KEY:			0001022899
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-BUSINESS SERVICES, NEC [7389]
		IRS NUMBER:				061390025
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010
		BUSINESS PHONE:		(212) 994-8200

	MAIL ADDRESS:	
		STREET 1:		149 FIFTH AVENUE
		STREET 2:		SUITE 500
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10010

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Atrinsic, Inc.
		DATE OF NAME CHANGE:	20090630

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NEW MOTION, INC.
		DATE OF NAME CHANGE:	20070504

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	MPLC, Inc.
		DATE OF NAME CHANGE:	20050608
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2020-07-18</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0001022899</issuerCik>
        <issuerName>Protagenic Therapeutics, Inc.\new</issuerName>
        <issuerTradingSymbol>PTIX</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001711184</rptOwnerCik>
            <rptOwnerName>Buell Jennifer</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>149 FIFTH AVE, SUITE 500</rptOwnerStreet1>
            <rptOwnerStreet2></rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10010</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>1</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>0</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <derivativeTable>
        <derivativeTransaction>
            <securityTitle>
                <value>PTIX Common stock Options</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>1.75</value>
            </conversionOrExercisePrice>
            <transactionDate>
                <value>2020-07-18</value>
            </transactionDate>
            <deemedExecutionDate></deemedExecutionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>A</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionTimeliness></transactionTimeliness>
            <transactionAmounts>
                <transactionShares>
                    <value>145000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>1.75</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <exerciseDate>
                <value>2020-07-18</value>
            </exerciseDate>
            <expirationDate>
                <value>2030-07-18</value>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>PTIX Common Stock, Par Value $0.0001</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>145000</value>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>145000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeTransaction>
    </derivativeTable>

    <remarks>100,000 of the options vest monthly over 48 months, commencing on the date of grant, while the other 45,000 options vest monthly over 12 months. Exhibit 24.2-Power of Attorney</remarks>

    <ownerSignature>
        <signatureName>/s/ Jennifer Buell</signatureName>
        <signatureDate>2020-07-21</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.2
<SEQUENCE>2
<FILENAME>ex24-2.htm
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Exhibit
24.2</B></FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">July
20, 2020</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">POWER
OF ATTORNEY</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">KNOW
ALL BY THESE PRESENTS, that the undersigned hereby constitutes and appoints Alexander K. Arrow, MD as the undersigned&rsquo;s
true and lawful attorney-in-fact to: (i) execute for and on behalf of the undersigned, in the undersigned&rsquo;s capacity as
an officer and/or of Protagenic Therapeutics, Inc., a Delaware corporation (the &ldquo;Company&rdquo;), Forms 3, 4 and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the rules thereunder; (ii) do and perform any and all acts for and
on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4 and 5 and timely file
such form with the United States Securities and Exchange Commission and any stock exchange or similar authority; and (iii) take
any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in- fact, may
be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed
by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain
such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact&rsquo;s discretion. The undersigned hereby
grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite,
necessary or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes
as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and
confirming all that such attorney-in-fact, or such attorney-in-fact&rsquo;s substitute or substitutes, shall lawfully do or cause
to be done by virtue of this power of attorney and the rights and powers herein granted. The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company
assuming, any of the undersigned&rsquo;s responsibilities to comply with Section 16 of the Securities Exchange Act of 1934. This
Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4 and 5 with
respect to the undersigned&rsquo;s holdings of and transactions in securities issued by the Company, unless earlier revoked by
the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">IN
WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of date first written above.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 50%; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Jennifer
    Buell</FONT></TD></TR>
<TR STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; text-align: left"><IMG SRC="ex24-2_001.jpg" ALT="" STYLE="height: 106; width: 200"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></P>

<!-- Field: Page; Sequence: 1; Options: Last -->
    <DIV STYLE="margin-bottom: 6pt; border-bottom: Black 1.5pt solid"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font-size: 10pt"><TR STYLE="vertical-align: top; text-align: left"><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp;</FONT></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>ex24-2_001.jpg
<TEXT>
begin 644 ex24-2_001.jpg
M_]C_X  02D9)1@ ! 0$ 9 !D  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" ": 2,# 2(  A$! Q$!_\0
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M8H 6BBB@ HHHH ***, T %%%% !128HP* %HHQ10 4444 )10>E':@!:***
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MWO)8G&&LM.Q''SVS@*?^^*Z;1OA/X*T(*T&A07$H(_>W>9SD=\-D#\ *U_\
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M?5CU)]S53_A._"'_ $->A_\ @QA_^*H_X3OPA_T->A_^#&'_ .*H Z"BN?\
M^$[\(?\ 0UZ'_P"#&'_XJC_A._"'_0UZ'_X,8?\ XJ@#H**Y_P#X3OPA_P!#
M7H?_ (,8?_BJ/^$[\(?]#7H?_@QA_P#BJ .@HK(T[Q+H6KSM;Z7K6G7TZJ7:
M.UNDE8+D#)"DG&2!GW%:] !1110 4444 %%%% !1110 4444 %%%% !1110
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MAHFA1GEUA02.!Z<AQ^3#ZTO_  IJ\U@EO%GC75]45F#&")O*BXQQM)8=NP%
M'6:Y\2O"'A[>M_KUIYJ'!A@;SI ?0JF<?CBN.?XMZUXAS%X%\'WU_G<!>7J^
M7""#CL<'\6!KKM$^&'@W0&5[+0;9I@<B6Y!F8'U!?./PQ77*H50J@ #@ =J
M/(V^'WCGQ>6_X33Q7]DL7SG3M*&T$$=&; 'KUW_6NT\-?#[PQX257TK2HUN
M,?:9?WDI_P"!'I^&!7544 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !7C?C'6;_ .(WB5O ?AJ=H]-@8'6+
M^/E0H/,8/].Y&.@-:/Q'\8W\U]'X&\),9=?OQMN)D;BSB(Y)8?=..<]0.>I%
M==X+\'6'@GP]%IEDH9^&N)R/FFDQRQ]NP'84 :6B:+8>'=(M]+TR!8;2W7:B
MCJ?4D]R3R36G110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %<1\2O&%UX3T.!=,M9+
MC5M1F^RV2@9"N1]X^N.P[GVS7;TAH X7X<^!/^$3L9KS4I3=>(-0;S;ZZ)S@
MGG8I] >I[GVP!W=%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
? %%%% !1110 4444 %%%% !1110 4444 %%%% '_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
